Companies

Edgewise Therapeutics, Inc. (EWTX) SEC filings

CIK 0001710072 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2023FY2022FY2021
Net income (USD)-67.6 M-42.8 M-17.1 M
Diluted EPS (USD/shares)-1.63-1.26

Latest filings

FiledFormDescriptionPeriod
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-08-174/APRIMARY DOCUMENT2026-08-12
2026-08-174/APRIMARY DOCUMENT2026-08-12
2026-08-174/APRIMARY DOCUMENT2026-08-12
2026-08-174/APRIMARY DOCUMENT2026-08-12
2026-08-174/APRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13144144
2026-08-06SCHEDULE 13GSCHEDULE 13G
2026-08-0610-Q10-Q2026-06-30
2026-08-068-KFORM 8-K items 2.02,9.012026-08-06
2026-07-174PRIMARY DOCUMENT2026-06-05
2026-07-168-K/AFORM 8-K/A items 9.012026-07-10
2026-07-138-KFORM 8-K items 2.01,7.01,9.012026-07-10
2026-07-024PRIMARY DOCUMENT2026-07-01
2026-07-014PRIMARY DOCUMENT2026-07-01
2026-07-01144144

Forms on file (last 1,000): 4 174, 8-K 49, 144 28, 3 22, SC 13G/A 20, 10-Q 17, SC 13G 14, SCHEDULE 13G/A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=EWTX (0.002 USD), /gw/filings/filings?ticker=EWTX&form=8-K, /gw/filings/facts?ticker=EWTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange